Jun 08, 2021 / 12:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Hi. Good morning, everyone. My name is Matt Sykes with Goldman Sachs. I'm the senior research analyst for the life sciences tools and diagnostics sector. And this morning, we're happy to kick off the 42nd Annual Goldman Sachs Global Healthcare Conference with QIAGEN.
With me, I have Roland Sackers, the Chief Financial Officer; John Gilardi, the Vice President, Head of Corporate Communications, Investor Relations; and Phoebe Loh, the Senior Director of Investor Relations.
Thank you, everyone, for joining us.
I thought maybe what we start out is I kind of turn it over to you, Roland, to set the stage for us to talk about perhaps the most recent quarter, expectations for the year, and just kind of set us up with how you're thinking about things these days.
Roland Sackers - QIAGEN N.V. - CFO, MD & Member of Management Board
Yes. Thanks, Matt. And again, thanks for having us. And as I said before, I'm very much looking forward to a real-life
Qiagen NV at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers